Suicide is a major public health concern, and the 11th leading cause of death in the United States. The rate of suicide in the US is 11 per 100,000. In 2003, there were over 30,000 deaths by suicide. During the present funding period, we found changes in serotonin neurons that appear to be functionally in the opposite direction to changes in the cortical terminal fields. We propose a new biologic model of suicide where the terminal field changes are indicative of impaired serotonin transmission, while the serotonin neurons indicate a compensatory or homeostatic response. We propose to further test this model by doing more detailed dorsal raphe subnuclei analyses since our receptor mapping studies suggest that the serotonin terminal field effects associated with suicide are not widespread but are confined to certain parts of the ventral prefrontal cortex and other brain regions, suggesting that not all parts of the DRN and MRN are involved. We also seek to prove a specific relationship to suicide by studying suicide in two different major psychiatric disorders. We will examine fully characterized groups of depressed suicides (MOD, n=15), schizophrenic suicides without major depression (SZ, n=15) and non-psychiatric controls (n=15). In this revised application, we have addressed the concerns of the reviewers and propose the following specific aims.
Specific Aim 1. We will determine whether the expression levels of neuronal tryptophan hydroxylase (TPH2) mRNA in neurons of the dorsal (DRN) and median (MRN) raphe nuclei in suicides are altered at the level of individual neurons in suicides relative to nonpsychiatric controls. We will also determine whether transcript levels are altered throughout the DRN and MRN or localized to specific DRN subnuclei. We hypothesize that MOD and SZ suicides will overexpress TPH2 at a per neuron level in the DRN and MRN, and that this effect will be confined to certain subnuclei.
Specific Aim 2. We will quantify TPH2-IR in serotonin nerve terminals in the prefrontal cortex (PFC, ventral and dorsal). Given the data indicating supporting impaired serotonin transmission in the cortex, we hypothesize that the TPH2-IR will be lower in the ventral prefrontal cortex of suicides contributing to deficient levels of serotonin. Changes in dorsal PFC will be related to MOD or SZ.
Specific Aim 3. We will determine whether the non-serotonergic DRN and MRN neurons are GABAergic. Our pilot data suggest fewer non-serotonergic neurons in the DRN and we hypothesize that there will be fewer GABA neurons in the DRN of suicides. Our study will help differentiate the neurochemical correlates of MOD or SZ versus suicide at the level of source (DRN and MRN) neurons and target cortical elements.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH040210-25
Application #
7812192
Study Section
Neural Basis of Psychopathology, Addictions and Sleep Disorders Study Section (NPAS)
Program Officer
Meinecke, Douglas L
Project Start
1990-02-01
Project End
2012-04-30
Budget Start
2010-05-01
Budget End
2011-04-30
Support Year
25
Fiscal Year
2010
Total Cost
$478,394
Indirect Cost
Name
Columbia University (N.Y.)
Department
Psychiatry
Type
Schools of Medicine
DUNS #
621889815
City
New York
State
NY
Country
United States
Zip Code
10032
Fitzgerald, Megan L; Kassir, Suham A; Underwood, Mark D et al. (2017) Dysregulation of Striatal Dopamine Receptor Binding in Suicide. Neuropsychopharmacology 42:974-982
Donaldson, Z R; le Francois, B; Santos, T L et al. (2016) The functional serotonin 1a receptor promoter polymorphism, rs6295, is associated with psychiatric illness and differences in transcription. Transl Psychiatry 6:e746
Kumar, J S Dileep; Underwood, Mark D; Simpson, Norman R et al. (2016) Autoradiographic Evaluation of [(18)F]FECUMI-101, a High Affinity 5-HT1AR Ligand in Human Brain. ACS Med Chem Lett 7:482-6
Yin, Honglei; Galfalvy, Hanga; Pantazatos, Spiro P et al. (2016) GLUCOCORTICOID RECEPTOR-RELATED GENES: GENOTYPE AND BRAIN GENE EXPRESSION RELATIONSHIPS TO SUICIDE AND MAJOR DEPRESSIVE DISORDER. Depress Anxiety 33:531-540
Yin, Honglei; Pantazatos, Spiro P; Galfalvy, Hanga et al. (2016) A pilot integrative genomics study of GABA and glutamate neurotransmitter systems in suicide, suicidal behavior, and major depressive disorder. Am J Med Genet B Neuropsychiatr Genet 171B:414-426
Bach, Helene; Arango, Victoria; Kassir, Suham A et al. (2016) Cigarette Smoking and Tryptophan Hydroxylase 2 mRNA in the Dorsal Raphe Nucleus in Suicides. Arch Suicide Res 20:451-62
Pantazatos, Spiro P; Andrews, Stuart J; Dunning-Broadbent, Jane et al. (2015) Isoform-level brain expression profiling of the spermidine/spermine N1-Acetyltransferase1 (SAT1) gene in major depression and suicide. Neurobiol Dis 79:123-34
Haghighi, Fatemeh; Xin, Yurong; Chanrion, Benjamin et al. (2014) Increased DNA methylation in the suicide brain. Dialogues Clin Neurosci 16:430-8
Bach, Helene; Huang, Yung-Yu; Underwood, Mark D et al. (2014) Elevated serotonin and 5-HIAA in the brainstem and lower serotonin turnover in the prefrontal cortex of suicides. Synapse 68:127-30
Bach, Helene; Arango, Victoria; Kassir, Suham A et al. (2014) Alcoholics have more tryptophan hydroxylase 2 mRNA and protein in the dorsal and median raphe nuclei. Alcohol Clin Exp Res 38:1894-901

Showing the most recent 10 out of 92 publications